(NASDAQ: KMTS) Kestra Medical Technologies's forecast annual revenue growth rate of 24.96% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.5%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.77%.
Kestra Medical Technologies's revenue in 2026 is $95,126,000.On average, 9 Wall Street analysts forecast KMTS's revenue for 2027 to be $7,943,568,468, with the lowest KMTS revenue forecast at $7,352,855,299, and the highest KMTS revenue forecast at $8,356,130,047. On average, 9 Wall Street analysts forecast KMTS's revenue for 2027 to be $8,190,871,006, with the lowest KMTS revenue forecast at $7,862,110,998, and the highest KMTS revenue forecast at $8,449,308,017.
In 2028, KMTS is forecast to generate $11,425,142,815 in revenue, with the lowest revenue forecast at $9,909,096,218 and the highest revenue forecast at $12,263,744,547.